Has Rebekah Fannin received payments from drug or device companies?

Yes. Drug and device makers reported $1,576 in general payments to Rebekah Fannin across 81 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rebekah Fannin did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rebekah Fannin come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rebekah Fannin

Family · Akron, OHNPI 1386307031

Payments from drug & device makers

$1,576in general payments, 2019–2025

Across 81 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$628
Bayer$126
Lilly USA, LLC$124
Insulet Corporation$99
AstraZeneca$82
Corcept Therapeutics$57
plus $460 from 15 others

What the payments were for

Food & beverage$1,55298%
Education$242%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	36	$628
Bayer	3	$126
Lilly USA, LLC	7	$124
Insulet Corporation	3	$99
AstraZeneca(2 entities)	4	$82
Corcept Therapeutics	2	$57
Antares Pharma, Inc.	3	$52
Xeris Pharmaceuticals, Inc.	3	$52
Dexcom, Inc.	2	$44
Radius Health, Inc.	2	$38
Amgen	2	$36
Boehringer Ingelheim	2	$35
Amarin Pharma, Inc.	2	$33
Amryt Pharma Holdings Ltd	2	$29
Novartis	2	$27
OPKO Pharmaceuticals, LLC	1	$24
BETA Bionics, Inc.	1	$23
Medtronic	1	$21
IBSA Pharma Inc.	1	$16
Sanofi-aventis U.S. LLC	1	$15
Tandem Diabetes Care, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

RYBELSUS$119
Ozempic$102

How this compares

$1,576 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	43	$55,132
JardianceEmpagliflozin	50	$42,899
Tresiba Flextouch U-200Insulin Degludec	21	$21,634
TrulicityDulaglutide	15	$19,048
FarxigaDapagliflozin Propanediol	24	$17,705
JanuviaSitagliptin Phosphate	15	$10,729
TradjentaLinagliptin	17	$10,439
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog	13	$10,221
Tresiba Flextouch U-100Insulin Degludec	23	$9,683
Humalog Kwikpen U-100Insulin Lispro	26	$5,979
Novolog FlexpenInsulin Aspart	22	$4,152
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	36	$3,910
Levothyroxine Sodium	233	$2,195
Cinacalcet Hcl	13	$2,019
Nano 2nd Gen Pen NeedlePen Needle, Diabetic	18	$1,807

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$628	$55,13243 claims
Boehringer IngelheimJardiance, Tradjenta	$35	$53,33867 claims
Lilly USA, LLCTrulicity	$124	$19,04815 claims
AstraZenecaFarxiga	$82	$17,70524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Akron

Eileen FauldsLewis Center$991K
Leigh Ann PanschDayton$670K
Natalie BelliniMayfield Heights$582K
Kaitlyn LovettMontgomery$286K
Amy RossDayton$281K
Renee OttSandusky$179K
Megan MillerSpringfield$156K
George KnightCincinnati$130K
Jillian HuntCincinnati$116K
Florence StewartNew Albany$113K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →